Picture of HAMLET Pharma AB logo

HAMLET TO4 B HAMLET Pharma AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for HAMLET Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments15.510.613.27.4739.6
Net Total Receivables0.4220.4850.7540.4960.847
Prepaid Expenses
Total Other Current Assets
Total Current Assets16.211.214.512.741.7
Net Property, Plant And Equipment0.3960.0810.0450.0090
Total Assets16.611.314.612.741.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.773.254.089.993.72
Total Long Term Debt
Total Debt
Total Liabilities1.773.254.089.993.72
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity14.88.0310.52.7538
Total Liabilities & Shareholders' Equity16.611.314.612.741.7
Total Common Shares Outstanding